000028.SZ
China National Accord Medicines Corporation Ltd.
ShenzhenCNYEQUITY
Healthcare
DELAYED
Last price
19.59
▲ 0.12 (0.62%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
19.38
Prev close
19.47
Day high
19.65
Day low
19.31
Volume
2.34M
Market cap
$11.99B
P/E (TTM)
10.94
52W range
18.70 – 24.94
Day trading desk
Gap from prior close
-0.46%
Prior close 19.47
VWAP
19.58
+0.03% from price
Relative volume
2.69×
Unusually busy
Session range
1.76%
19.31 – 19.65
Position in range
82%
Near session high
ATR (14D)
0.43
2.17% of price
Prior day high
19.80
PDH
Prior day low
19.40
PDL
Bid / ask spread
—
Quote not published
Session volume
8.85M
Avg 3.30M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-2.20%
-0.8%
1M
-2.83%
-6.6%
3M
-8.61%
-11.7%
6M
-17.56%
-28.6%
YTD
-12.26%
-24.5%
1Y
-15.73%
-35.7%
3Y
-42.07%
-116.2%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on 000028.SZ open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
414.56M
Total on file
Fundamentals
Market cap$11.99B
Enterprise value—
Revenue (TTM)$72.89B
Gross profit$40.15B
EBITDA$1.92B
Net income$1.08B
EPS (TTM)$1.79
Free cash flow—
Total cash—
Total debt—
Book value / share$30.40
Shares outstanding533.74M
Float263.24M
Short % of float—
Dividend yield3.16%
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E10.94
Forward P/E7.00
PEG ratio—
Price / sales—
Price / book0.64
EV / revenue—
EV / EBITDA—
Gross margin55.09%
Operating margin2.60%
Profit margin1.48%
Return on equity4.74%
Return on assets—
Debt / equity18.69
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $73.42B | $74.38B | $75.48B | $73.44B | -1.3% |
| Operating revenue | $73.42B | $74.38B | $75.48B | $73.44B | -1.3% |
| Cost of revenue | $65.58B | $66.13B | $66.43B | $64.52B | -0.8% |
| Gross profit | $7.84B | $8.25B | $9.05B | $8.93B | -5.0% |
| Research & development | $19.99M | $24.55M | $26.82M | $9.07M | -18.6% |
| Selling, general & admin | $1.43B | $1.43B | $1.64B | $1.65B | -0.3% |
| Total operating expense | $5.99B | $6.58B | $6.55B | $6.51B | -8.8% |
| Operating income | $1.85B | $1.67B | $2.50B | $2.41B | +10.3% |
| Net interest income | -$184.33M | -$237.57M | -$207.49M | -$189.08M | +22.4% |
| Pre-tax income | $1.51B | $575.47M | $2.47B | $2.31B | +162.2% |
| Tax provision | $380.67M | $338.47M | $514.74M | $539.33M | +12.5% |
| Net income | $1.14B | $642.49M | $1.60B | $1.49B | +76.8% |
| Net income to common | $1.14B | $642.49M | $1.60B | $1.49B | +76.8% |
| Basic EPS | 1.85 | 1.05 | 2.61 | 2.43 | +77.4% |
| Diluted EPS | 1.85 | 1.05 | 2.61 | 2.43 | +77.4% |
| EBIT | $1.70B | $833.77M | $2.72B | $2.57B | +104.3% |
| EBITDA | $3.06B | $2.49B | $4.15B | $3.88B | +22.9% |
| Basic shares | 612.51M | 614.56M | 612.96M | 612.50M | -0.3% |
| Diluted shares | 612.51M | 614.56M | 612.96M | 612.50M | -0.3% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $7.80B | $7.41B | $6.50B | $6.02B | — | +5.3% |
| Cash & short-term investments | $7.80B | $7.41B | $6.50B | $6.02B | — | +5.3% |
| Accounts receivable | $21.54B | $19.38B | $18.16B | $13.76B | — | +11.2% |
| Inventory | $8.12B | $7.41B | $7.99B | $7.84B | — | +9.7% |
| Total current assets | $40.20B | $37.58B | $36.37B | $31.71B | — | +7.0% |
| Property, plant & equipment | $2.69B | $3.48B | $3.72B | $3.41B | — | -22.6% |
| Goodwill & intangibles | $2.01B | $2.34B | $3.36B | $3.40B | — | -14.0% |
| Total assets | $49.10B | $47.56B | $47.57B | $42.62B | — | +3.2% |
| Total current liabilities | $26.11B | $24.80B | $24.34B | $21.03B | — | +5.3% |
| Current debt | $2.60B | $3.02B | $2.61B | $1.26B | — | -13.7% |
| Long-term debt | — | — | — | $17.50M | $71.64M | — |
| Total debt | $4.25B | $5.33B | $5.08B | $3.52B | — | -20.2% |
| Total liabilities | $27.47B | $26.80B | $26.59B | $23.17B | — | +2.5% |
| Retained earnings | $13.51B | $12.58B | $12.31B | $11.12B | — | +7.4% |
| Shareholder equity | $18.61B | $17.67B | $17.41B | $16.13B | — | +5.3% |
| Working capital | $14.09B | $12.77B | $12.03B | $10.68B | — | +10.3% |
| Net tangible assets | $16.60B | $15.33B | $14.05B | $12.73B | — | +8.3% |
| Shares issued | 612.22M | 612.22M | 612.22M | 612.22M | — | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $1.13B | $237.00M | $1.96B | $1.77B | +376.1% |
| Depreciation & amortisation | $1.26B | $1.55B | $1.43B | $1.31B | -18.4% |
| Change in working capital | -$978.03M | $2.10M | -$519.86M | -$1.01B | -46,757.0% |
| Operating cash flow | $1.64B | $3.27B | $2.94B | $2.56B | -49.9% |
| Capital expenditure | -$217.35M | -$282.70M | -$322.21M | -$322.19M | +23.1% |
| Investing cash flow | -$102.92M | -$150.69M | -$135.43M | -$342.82M | +31.7% |
| Dividends paid | -$386.29M | -$603.77M | -$559.07M | -$574.19M | +36.0% |
| Financing cash flow | -$1.36B | -$1.83B | -$2.41B | -$1.51B | +25.6% |
| Free cash flow | $1.42B | $2.99B | $2.61B | $2.24B | -52.4% |
| End cash position | $7.30B | $7.12B | $5.84B | $5.44B | +2.4% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $17.82B | $18.29B | — | $18.50B | $18.29B | $17.91B | -2.6% |
| Operating revenue | $17.82B | $18.29B | — | $18.50B | $18.29B | $17.91B | -2.6% |
| Cost of revenue | $16.05B | $16.23B | — | $16.46B | $16.40B | $15.80B | -1.1% |
| Gross profit | $1.78B | $2.06B | — | $2.04B | $1.89B | $2.11B | -13.9% |
| Research & development | $1.51M | $3.43M | — | $5.71M | $5.92M | $5.31M | -55.8% |
| Selling, general & admin | $1.30B | -$2.82B | $3.61B | -$747.25M | $1.39B | — | +146.1% |
| Total operating expense | $1.33B | $1.64B | — | $1.54B | $1.43B | $1.76B | -18.5% |
| Operating income | $442.66M | $425.13M | — | $500.65M | $462.52M | $353.42M | +4.1% |
| Net interest income | -$34.31M | -$64.40M | — | -$43.96M | -$38.25M | -$54.52M | +46.7% |
| Pre-tax income | $376.86M | $191.37M | — | $479.79M | $438.33M | -$780.99M | +96.9% |
| Tax provision | $71.70M | $82.41M | — | $114.87M | $90.65M | $77.67M | -13.0% |
| Net income | $287.46M | $178.81M | — | $337.91M | $328.00M | -$423.05M | +60.8% |
| Net income to common | $287.46M | $178.81M | — | $337.91M | $328.00M | -$423.05M | +60.8% |
| Basic EPS | 0.47 | — | — | — | 0.54 | — | — |
| Diluted EPS | 0.47 | — | — | — | 0.54 | — | — |
| EBIT | $410.19M | $254.55M | — | $527.26M | $481.96M | -$721.25M | +61.1% |
| EBITDA | $410.19M | $254.55M | — | $527.26M | $481.96M | -$721.25M | +61.1% |
| Basic shares | 608.09M | — | — | — | 611.52M | — | — |
| Diluted shares | 608.09M | — | — | — | 611.52M | — | — |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $5.18B | $7.80B | — | $6.80B | $5.54B | $7.41B | -33.6% |
| Cash & short-term investments | $5.18B | $7.80B | — | $6.80B | $5.54B | $7.41B | -33.6% |
| Accounts receivable | $23.90B | $21.54B | — | $23.75B | $23.59B | $19.38B | +11.0% |
| Inventory | $8.47B | $8.12B | — | $8.06B | $8.02B | $7.41B | +4.3% |
| Total current assets | $40.31B | $40.20B | — | $40.86B | $40.14B | $37.58B | +0.3% |
| Property, plant & equipment | $2.56B | $2.69B | — | $3.08B | $3.33B | $3.48B | -5.0% |
| Goodwill & intangibles | $2.00B | $2.01B | — | $2.32B | $2.33B | $2.34B | -0.4% |
| Total assets | $49.12B | $49.10B | — | $50.43B | $50.02B | $47.56B | +0.1% |
| Total current liabilities | $25.90B | $26.11B | — | $27.46B | $27.04B | $24.80B | -0.8% |
| Current debt | $2.52B | $2.60B | — | $4.34B | $3.73B | $3.02B | -3.1% |
| Total debt | $4.10B | $4.25B | — | $6.32B | $5.97B | $5.33B | -3.7% |
| Total liabilities | $27.21B | $27.47B | — | $29.18B | $28.92B | $26.80B | -0.9% |
| Retained earnings | $13.80B | $13.51B | — | $13.04B | $12.90B | $12.58B | +2.1% |
| Shareholder equity | $18.90B | $18.61B | — | $18.14B | $18.00B | $17.67B | +1.5% |
| Working capital | $14.41B | $14.09B | — | $13.40B | $13.10B | $12.77B | +2.3% |
| Net tangible assets | $16.89B | $16.60B | — | $15.81B | $15.67B | $15.33B | +1.8% |
| Shares issued | 612.22M | 612.22M | 612.22M | 612.22M | 612.22M | — | 0.0% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|
| Capital expenditure | -$26.97M | -$44.18M | -$50.09M | -$64.31M | -$79.36M | +39.0% |
| Investing cash flow | -$23.22M | -$25.85M | -$4.13M | -$59.94M | -$79.45M | +10.2% |
| Dividends paid | -$37.29M | -$44.74M | -$251.96M | -$47.12M | -$54.28M | +16.7% |
| Financing cash flow | $332.39M | -$48.37M | -$754.90M | $92.06M | $154.99M | +787.1% |
| Free cash flow | -$2.96B | $2.06B | $1.78B | -$1.88B | $1.91B | -244.0% |
| End cash position | $4.67B | $7.30B | $6.41B | $5.34B | $7.12B | -36.0% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.53 | 0.52 | -1.9% |
| Mar 2026 | 0.57 | 0.47 | -17.5% |
| Dec 2025 | 0.55 | 0.28 | -48.5% |
| Sep 2025 | 0.53 | 0.45 | -13.8% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.50 | 1 | $0 | — |
| Next quarter | 0.35 | 1 | $0 | — |
| Current year | 1.99 | 1 | $77.20B | +5.1% |
| Next year | 2.03 | 4 | $78.00B | +1.0% |
Analyst targets & ownership
Mean target$26.30
High target$33.03
Low target$16.80
Implied upside34.24%
Analyst count4
ConsensusBUY
Strong buy / Buy1 / 2
Hold0
Sell / Strong sell1 / 0
Held by insiders67.24%
Held by institutions3.63%
Institutions holding52
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
20.02
-2.16% from price
SMA 20
20.35
-3.75% from price
SMA 50
20.36
-3.76% from price
SMA 100
21.34
-8.19% from price
SMA 200
22.23
-11.88% from price
EMA 12
20.01
-2.11% from price
EMA 26
20.26
-3.30% from price
EMA 50
20.54
-4.61% from price
RSI (14)
36.9
Neutral
MACD (12,26,9)
-0.25
Hist -0.10
ATR (14)
0.43
2.17% of price
Realised vol 30D
20.2%
Annualised
Bollinger upper
21.27
20, 2σ
Bollinger lower
19.44
20, 2σ
50 / 200 cross
Death
20.36 vs 22.23
Trend bias
Below 200
-11.88%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
-0.04
Less volatile than market
Correlation to SPY
-0.03
Largely independent
Realised vol 30D
20.2%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-23.0%
Peak to trough
Max drawdown 5Y
-58.4%
Peak to trough
ATR 14
0.43
2.17% of price
Beta (reported)
—
5Y monthly, from filing
Dividends & splits
Forward rate$0.62 / yr
Forward yield3.16%
5-year avg yield2.12%
Payout ratio18.58%
Ex-dividend dateJun 24, 2026
Next pay date—
Last split1.1:1
Split dateJun 24, 2026
Headlines
Aegon Increases Share Buyback Program
MT Newswires · 4m ago
Nvidia opens talks with Rebellions on potential AI chip partnership
Verdict · 4m ago
The National carrier of the Hashemite Kingdom of Jordan, Royal Jordanian Airlines Selects Ramco Systems to Power Its Next Phase of Growth
PR Newswire · 7m ago
Metals Exploration targets December 2026 gold output at La India project
Mining Technology · 8m ago
3 Financials Stocks We’re Skeptical Of
StockStory · 13m ago
Oil falls as Trump pledges economic war on Iran
AFP · 13m ago
How Tech Lights Up Longmen Grottoes
PR Newswire · 13m ago
Galileo Robotics Unveils Galileo X at WRC 2026, Breaking Conventional Form Factors with Its "Embodied Ground Mobility System"
PR Newswire · 14m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.